Healthy Male Subjects clinical trials

Explore recruiting healthy male subjects clinical trials.

Recruiting healthy male subjects studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Healthy Male Subjects trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, open-label, single dose, cross-over study to evaluate the drug-drug interaction between Proscar 5 mg, film-coated tablets and Cialis 5 mg film-coated tablets when co-administered versus the administration of each product alone in healthy volunteers under fasting conditions. Study no. FIN-TAD-DDI-03-24

Czechia

Human Pharmacology (Phase I)- Other EU CTIS Study details

Open label, single-center, cross-over randomized, relative bioavailability study comparing 4 new BF2.649 (pitolisant) tablet formulations versus the reference pitolisant (Wakix®) tablet formulation after single oral administrations in healthy male subjects.

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A randomised, single-blind, placebo-controlled trial to investigate safety, tolerability, and pharmacokinetics of single rising doses of BI 3000202 administered as tablet to healthy male subjects, and a randomised, open-label, single-dose, two-way cross-over relative bioavailability comparison of BI 3000202 as tablet with and without food in healthy male subjects

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A randomized, double-blind, single-center, 2-period cross-over Phase I study to assess the tolerability, safety and pharmacokinetics of antidepressant doses of oral ketamine hydrochloride prolonged release tablets (KET01) compared to intranasal esketamine in healthy male subjects

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

AZ-3102: Protocol AZA-001-31-02: An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Relative bioavailability of BI 1810631 following oral administration under fed and fasted conditions in healthy male subjects (an open-label, randomised, single-dose, two-way crossover trial)

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Healthy Male Subjects trials by city

Healthy Male Subjects in Toronto Healthy Male Subjects in Vancouver Healthy Male Subjects in Montreal Healthy Male Subjects in Calgary Healthy Male Subjects in Edmonton Healthy Male Subjects in Ottawa Healthy Male Subjects in Winnipeg Healthy Male Subjects in Quebec City Healthy Male Subjects in Hamilton Healthy Male Subjects in Kitchener Healthy Male Subjects in London Healthy Male Subjects in Halifax Healthy Male Subjects in New York Healthy Male Subjects in Los Angeles Healthy Male Subjects in Chicago Healthy Male Subjects in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease